Concord Health Partners Announces $250m Concord Innovation Fund II in Partnership with 3CR-Riverbend
Updated: Feb 22, 2021
3CR-Riverbend has been engaged to raise capital for Concord Health Partners $250m new innovative healthcare fund. Their capital raise will primarily consist of family offices and fund of funds.
“We are excited to be partnered with a team as experienced as Concord’s.”
About Concord Health Partners
Concord Health Partners is a healthcare focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies and solutions that lower costs, improve quality and/or expand access to care.
Concord’s team of experienced professionals has a broad network of strategic relationships across the healthcare industry including both for-profit and not-for-profit sectors. Concord’s investment strategy creates a powerful alignment of interests between investors and portfolio companies intended to mitigate risk and create incremental value for all key stakeholders. Their differentiated strategy expands access to resources, leverages proprietary sourcing channels and accelerates growth in portfolio companies.
James T. Olsen
Founder & Managing Partner
James T. Olsen is the Founder & Managing Partner of Concord and a member of Concord’s Investment Committee.
Mr. Olsen has over 24 years of experience in healthcare investment banking and investment advisory services. Prior to founding Concord in 2017, Mr. Olsen was Managing Director & Head of Not-for-Profit Healthcare Investment Banking at Jefferies Group LLC (‘‘Jefferies’’). Prior to Jefferies, Mr. Olsen served as Managing Director & Head of Not-for-Profit Healthcare Mergers & Acquisitions at Bank of America Merrill Lynch.
Co-Founder & Partner
Mr. Swedish has been extensively recognized for his leadership in the healthcare field. For 12 years in a row, Modern Healthcare named him one of the 100 Most Influential People in Healthcare.
Mr. Swedish is a Co-Founder and Partner at Concord and a member of the Firm’s Investment Committee. Mr. Swedish has more than 45 years of healthcare leadership experience. Most recently, Mr. Swedish was Chairman, President & Chief Executive Officer of Anthem, Inc., a Fortune 29 company and the nation’s leading health benefits provider. He also served for more than 25 years as CEO for several major health systems, most recently Trinity Health, a 22-state integrated health care delivery system.
Some of Concord’s previous investments include:
Post Acute Analytics, Loyal, Cedar, Cylera, Bright.md, Pieces Technologies, Inc, CI Security, Mednition, Inc., VitalTech Holdings, Inc., MIVI Neuroscience, Inc., Flexwise Health, Inc., Proton Therapy Partners
Learn more about Concord Health Partners Here.
3CR - Riverbend Capital Advisors is a family office & private equity advisory firm that specializes in equity & debt capital raises for high-caliber alternative investment managers and for small to mid-size privately owned businesses. Through 3CR and extensive prior work experiences, their team has built and maintains a vast network of large family offices and institutional investors throughout the United States.
Visit www.3cr-riverbend.com to learn more.
All securities assignments are completed through Avalon Securities, Ltd. a FINRA and SEC registered broker-dealer.